stellamune mycoplasma emulsión inyectable
elanco gmbh - mycoplasma hyopneumoniae inactivado, cepa nl 1042 - emulsiÓn inyectable - mycoplasma hyopneumoniae inactivado, cepa nl 1042 3,7 log10u elisa - mycoplasma - lechones
stellamune uno emulsión inyectable
elanco gmbh - mycoplasma hyopneumoniae inactivado, cepa nl 1042 - emulsiÓn inyectable - mycoplasma hyopneumoniae inactivado, cepa nl 1042 4,5-5,2 log10u elisa - mycoplasma - cerdos de engorde
stellamune mycoplasma
elanco valquimica, s.a - mycoplasma hyopneumoniae inactivado, cepa nl 1042 - emulsiÓn inyectable - excipientes: anfigen, tiomersal, edta (etilendiamino tetraacetico), polisorbato 80, parafina liquida, sorbitan monooleato, solucion salina - mycoplasma - porcino
suvaxyn m. hyo suspension inyectable para cerdos # suvaxyn m. hyo
zoetis spain s.l. - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 - suspensiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 1potencia relativa - mycoplasma - lechones
suvaxyn mh-one emulsion inyectable para porcino # suvaxyn mh-one
zoetis spain s.l. - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 - emulsiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 ≤1u elisa - mycoplasma - cerdos de engorde
porvaxin m.hyo emulsion inyectable para porcino
vetia animal health, s.a.u - mycoplasma hyopneumoniae, inactivado, cepa 1137/99 - emulsiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa 1137/99 1potencia relativa - mycoplasma - lechones
ingelvac mycoflex suspension inyectable para cerdos
boehringer ingelheim vetmedica gmbh - mycoplasma hyopneumoniae, inactivado, cepa j, b-3745 - suspensiÓn inyectable - mycoplasma hyopneumoniae, inactivado, cepa j, b-3745 1,0potencia relativa - mycoplasma - cerdos de engorde; cerdos de reposición
mhyosphere pcv id
laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cerdos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.
suvaxyn m. hyo
pfizer, s.l. - mycoplasma hyopneumoniae, inactivado, cepa p-5722-3 - suspensiÓn inyectable - excipientes: cloruro de sodio, tiomersal, carbopol, amaranto (ci=16185,e-123), agua para preparaciones inyectables, edta (etilendiamino tetraacetico) - mycoplasma - porcino
ingelvac® mycoflex
boehringer ingelheim - mycoplasma hyopneumoniae cepa j cultivos inactivados; impranflex® (polímeros de policrilamina) - mycoplasma hyopneumoniae cepa j cultivos inactivados ; impranflex® (polímeros de policrilamina) - prevención de la neumonía enzootica producida por mycoplasma hyopneumoniae. - porcinos